NCT01721135View on ClinicalTrials.gov

A Study to Evaluate the Effect of Two Different Repeat Doses of GSK2190915 on the QTc Interval.

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2010

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Asthma
Interventions
DRUG

GSK2190915 100mg

Film coated oral tablet

DRUG

GSK2190915 200mg

Film coated oral tablet

DRUG

moxifloxacin 400mg

Film coated oral tablet

DRUG

moxifloxacin placebo

Film coated oral tablet

DRUG

GSK2190915 placebo

Film coated oral tablet

Trial Locations (1)

NW10 7EW

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY